PTEN/MMAC1 mutations and EGFR amplification in glioblastomas

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5254-5257

  Liu, Wanguo ^a   James, C David ^a   Frederick, Lori ^a   Alderete, Benjamin E ^a   Jenkins, Robert B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MICROSATELLITE DNA;

ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CHROMOSOME 10; DNA DETERMINATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE MUTATION; GENETIC HETEROGENEITY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; DNA; DNA, NEOPLASM; EXONS; FRAMESHIFT MUTATION; GLIOBLASTOMA; HUMANS; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 0030724320     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bigner, S. H., Mark, J., Burger, P. C., Mahaley, M. S., Bullard, D. E., Muhlbaier, L. H., and Bigner, D. D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res., 48: 405-411, 1988.
2. James, C. D., Caribom, E., Dumanski, J., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48: 5546-5551, 1988.
3. Fujimoto, M., Fults, D. W., Thomas, G. A., Nakamura, Y., Heilbrun, M. P., White, R., Story, J. L., Naylor, S. L., Kagan-Hallet, K. S., and Sheridan, P. J. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics, 4: 210-214, 1989.
4. Ransom, D. T., Ritland, S. R., Moertel, C. A., Dahl, R. J., O'Fallon, J. R., Scheithauer, B. W., Kimmel, D. W., Kelly, P. J., Olopade, O. I., Diaz, M. O., and Jenkins, R. B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oliogo-astrocytomas. Genes Chromosomes Cancer, 5: 357-374, 1992.
5. Fults, D., and Pedone, C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer, 7: 173-177, 1993.
6. Karlbom, A. E., James, C. D., Boethius, J., Cavenee, W. K., Collins, V. P., Nordenskjold, M., and Larsson, C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum. Genet., 92: 169-174, 1993.
7. Steck, P. A., Lignon, A. H., Cheong, P., Yung, W. K., and Pershouse, M. A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer, 12: 255-261, 1995.
8. Rasheed, B. K., McLendon, R. E., Friedman, H. S., Friedman, A. H., Fuchs, H. E., Bigner, D. D., and Bigner, S. H. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene, 10: 2243-2246, 1995.
9. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Lignon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
10. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Janusz, P., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
11. Li, D-M., and Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57: 2130-2136, 1997.
12. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
13. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA, 84: 6899-6903, 1987.
14. Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., and Collins, V. P. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res., 51: 2164-2172, 1991.
15. Oefner, P. J., and Underhill, P. A. Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am. J. Hum. Genet., 57 (Suppl.): A266, 1995.
16. Hayward-Lester, A., Chilton, B. S., Underhill, P. A., Oefner, P. J., and Doris, P. S. Quantification of specific nucleic acids, regulated RNA processing and genomic polymorphisms using reversed-phase HPLC. In: F. Ferr (ed.), Gene Quantification. Basel: Birkhuser Vertag, 1996.
17. Giani, C., and Finocchiaro, G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res., 54: 6338-6339, 1994.
18. von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yasargil, M. G., Wiestler, O. D., and Seizinger, B. R. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg., 77: 295-301, 1992.
19. Leenstra, S., Biulsma, E. K., Oosting, J., Westerveld, A., Bosch, D. A., and Hulsebos, T. J. M. Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br. J. Cancer, 70: 684-689, 1994.
20. Leach, F. S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J. D., Smith, S., Hill, D. E., Sidransky, D., Kinzler, K. W., and Vogelstein, B. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53: 2231-2234, 1993.
21. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736-2739, 1993.
22. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.
23. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., and Louis, D. N. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.